Drug interaction label changes for URL's Colcrys
This article was originally published in Scrip
Executive Summary
URL Pharmaceuticals has updated the label of Colcrys (colchicine), its treatment for gout and familial Mediterranean fever (FMF), to reduce the dosing recommendations for patients who are taking HIV protease inhibitors that are boosted by low-dose ritonavir.